This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
07/07/15 - 11:37:54 AM ET (BATS BZX Real-time Price)
NVS Day's Range
NVS 52 Week Range
NVS Business Summary
Novartis AG researches, develops, manufactures, and markets a range of healthcare products worldwide.View NVS key stats
Novartis AG - NVS - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates Novartis AG as a
Buy with a ratings score of A-.
Report Snippet: We rate NOVARTIS AG (NVS) a BUY. This is based on the convergence of positive investment measures, which should help this stock outperform the majority of stocks that we rate. The company's strengths can be seen in multiple areas, such as its compelling growth in net income, reasonable valuation levels, good cash flow from operations, expanding profit margins and largely solid financial position with reasonable debt levels by most measures. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results.